Intelligent Bio Solutions, Inc. (INBS)
1.79
+0.03
(+1.70%)
USD |
NASDAQ |
Nov 06, 10:27
Intelligent Bio Solutions Enterprise Value : 2.721M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 2.721M |
| November 04, 2026 | 2.692M |
| November 03, 2026 | 2.750M |
| November 02, 2026 | 2.430M |
| October 30, 2026 | 2.721M |
| October 29, 2026 | 2.924M |
| October 28, 2026 | 2.459M |
| October 27, 2026 | 2.604M |
| October 26, 2026 | 2.372M |
| October 23, 2026 | 2.227M |
| October 22, 2026 | 2.503M |
| October 21, 2026 | 2.634M |
| October 20, 2026 | 2.459M |
| October 19, 2026 | 2.052M |
| October 16, 2026 | 1.965M |
| October 15, 2026 | 1.791M |
| October 14, 2026 | 1.82M |
| October 13, 2026 | 1.907M |
| October 12, 2026 | 1.994M |
| October 09, 2026 | 2.052M |
| October 08, 2026 | 2.169M |
| October 07, 2026 | 2.227M |
| October 06, 2026 | 2.198M |
| October 05, 2026 | 2.459M |
| October 02, 2026 | 2.430M |
| Date | Value |
|---|---|
| October 01, 2026 | 2.430M |
| September 30, 2026 | 2.459M |
| September 29, 2026 | 2.343M |
| September 28, 2026 | 2.401M |
| September 25, 2026 | 2.546M |
| September 24, 2026 | 2.576M |
| September 23, 2026 | 2.750M |
| September 22, 2026 | 2.837M |
| September 21, 2026 | 2.866M |
| September 18, 2026 | 3.273M |
| September 17, 2026 | 3.418M |
| September 16, 2026 | 3.331M |
| September 15, 2026 | 3.563M |
| September 14, 2026 | 3.622M |
| September 11, 2026 | 3.796M |
| September 10, 2026 | 3.970M |
| September 09, 2026 | 4.115M |
| September 08, 2026 | 3.854M |
| September 04, 2026 | 4.086M |
| September 03, 2026 | 4.290M |
| September 02, 2026 | 4.784M |
| September 01, 2026 | 4.668M |
| August 31, 2026 | 4.580M |
| August 28, 2026 | 4.464M |
| August 27, 2026 | 4.203M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sanara MedTech, Inc. | 323.70M |
| Anteris Technologies Global Corp. | 289.77M |
| 20/20 Biolabs, Inc. | -0.1454M |
| Quest Diagnostics, Inc. | 33.91B |
| Labcorp Holdings, Inc. | 36.03B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.917M |
| Revenue (Quarterly) | 1.146M |
| Total Expenses (Quarterly) | 5.054M |
| EPS Diluted (Quarterly) | -1.345 |
| Gross Profit Margin (Quarterly) | 21.68% |
| Profit Margin (Quarterly) | -341.9% |
| Earnings Yield | -527.7% |
| Normalized Earnings Yield | -514.45 |